
Nymox Pharmaceutical Corporation NYMX
Annual report 2024
added 03-07-2026
Nymox Pharmaceutical Corporation DSO Ratio 2011-2026 | NYMX
Annual DSO Ratio Nymox Pharmaceutical Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | 12.5 | 36.8 | 83.6 | 63.1 | 73.3 | 46.1 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 83.6 | 12.5 | 52.6 |
DSO Ratio of other stocks in the Biotechnology industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aptorum Group Limited
APM
|
20.6 | $ 0.79 | -1.15 % | $ 4.31 M | ||
|
Acorda Therapeutics
ACOR
|
48.3 | - | -24.86 % | $ 820 K | ||
|
AbCellera Biologics
ABCL
|
173 | $ 3.49 | 0.58 % | $ 1.04 B | ||
|
Frequency Therapeutics
FREQ
|
76.1 | - | - | $ 528 M | ||
|
I-Mab
IMAB
|
271 | - | - | $ 866 M | ||
|
AgeX Therapeutics
AGE
|
78.4 | - | -10.17 % | $ 12.2 K | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
84.7 | - | - | $ 40.3 B | ||
|
Alterity Therapeutics Limited
ATHE
|
16.2 K | $ 3.6 | 1.41 % | $ 8.66 B | ||
|
Aeglea BioTherapeutics
AGLE
|
216 | - | - | $ 1.01 B | ||
|
Ascendis Pharma A/S
ASND
|
132 | $ 225.98 | -1.32 % | $ 5 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.114 | - | - | $ 26.5 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.75 K | - | -1.52 % | $ 24.7 M | ||
|
Adverum Biotechnologies
ADVM
|
222 | - | - | $ 86.2 M | ||
|
Midatech Pharma plc
MTP
|
204 | - | -18.52 % | $ 27.3 M | ||
|
Advaxis
ADXS
|
88.1 | - | -9.65 % | $ 45.9 M | ||
|
BioCardia
BCDA
|
101 | $ 1.26 | -0.79 % | $ 26.7 M | ||
|
Anika Therapeutics
ANIK
|
77.3 | $ 14.2 | -0.7 % | $ 208 M | ||
|
Aeterna Zentaris
AEZS
|
146 | - | 5.93 % | $ 314 M | ||
|
Athersys
ATHX
|
22.6 | - | 3.77 % | $ 22.4 M | ||
|
Aptinyx
APTX
|
46.9 | - | -39.0 % | $ 4.57 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
21.2 | $ 6.68 | -4.57 % | $ 183 M | ||
|
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | ||
|
AVEO Pharmaceuticals
AVEO
|
47.5 | - | - | $ 521 M | ||
|
Ayala Pharmaceuticals
AYLA
|
61.7 | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
150 | $ 2.54 | -5.22 % | $ 16 M | ||
|
Certara
CERT
|
89.6 | $ 6.67 | 1.6 % | $ 1.07 B | ||
|
Can-Fite BioPharma Ltd.
CANF
|
28.1 | $ 3.6 | -4.0 % | $ 7.83 B | ||
|
CureVac N.V.
CVAC
|
13.6 | - | - | $ 867 M | ||
|
Aravive
ARAV
|
16.8 | - | -13.39 % | $ 1.45 M |